Recombinant IL-6R (Tocilizumab Biosimilar) anticorps

N° du produit ABIN7487791

Détail du produit anti-IL-6R (Tocilizumab Biosimilar) anticorps

Antigène: IL-6R (Tocilizumab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Mammalian Cells

Expression System: Mammalian cells

Clonalité: Monoclonal

Conjugué: Cet anticorp IL-6R (Tocilizumab Biosimilar) est non-conjugé

Application: ELISA

Fonction: Tocilizumab Biosimilar - Anti-IL-6R mAb

Attributs du produit: Antibody Type: IgG1Kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Classe de qualité: Research Grade

Isotype: IgG1 kappa

Information d'application

Restrictions: For Research Use only

Stockage

Buffer: PBS pH 7.5

Stock: 4 °C,-20 °C

Stockage commentaire: 4°C for short term, -20°C for long term

Détails sur IL-6R (Tocilizumab Biosimilar)

Antigène: IL-6R (Tocilizumab Biosimilar)

Abstract: IL-6R (Tocilizumab Biosimilar) Produits

Synonymes: anticorps CD126, anticorps IL-6R-1, anticorps IL-6RA, anticorps IL6Q, anticorps IL6RA, anticorps IL6RQ, anticorps gp80, anticorps interleukin 6 receptor, anticorps IL6R

Classe de substances: Biosimilar

Sujet: Tocilizumab
Tocilizumab, also known as atlizumab, is a recombinant humanized, anti-human monoclonal antibody (mAb) of the immunoglobulin G1κ subclass directed against soluble and membrane-bound interleukin-6 (IL-6) receptor (IL-6R) which plays an important role in immune response and is implicated in the pathogenesis of many diseases, such as autoimmune diseases, multiple myeloma and prostate cancer.

Numéro CAS: 375823-41-9